{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:21:36Z","timestamp":1790767296220,"version":"4.1.0"},"reference-count":14,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2020,9,29]]},"DOI":"10.1536\/ihj.20-024","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T22:04:54Z","timestamp":1599861894000},"page":"1084-1087","source":"Crossref","is-referenced-by-count":8,"title":["Pulmonary Hypertension Following Increased Dosing of Diazoxide in an Infant"],"prefix":"10.1536","volume":"61","author":[{"given":"Yuji","family":"Ohnishi","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Yamaguchi University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seigo","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yamaguchi University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Yasudo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yamaguchi University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasagu","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yamaguchi University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yamaguchi University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yamaguchi University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yildizdas D, Erdem S, K\u00fc\u00e7\u00fckosmanoglu O, Yilmaz M, Y\u00fcksel B. Pulmonary hypertension, heart failure and neutropenia due to diazoxide therapy. Adv Ther 2008; 25: 515-9.","DOI":"10.1007\/s12325-008-0049-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hansen JB. Towards selective Kir6.2\/SUR1 potassium channel openers, medicinal chemistry and therapeutic perspectives. Curr Med Chem 2006; 13: 361-76.","DOI":"10.2174\/092986706775527947"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Silvani P, Camporesi A, Mandelli A, Wolfler A, Salvo I. A case of severe diazoxide toxicity. Pediatr Anesth 2004; 14: 607-9.","DOI":"10.1111\/j.1460-9592.2004.01276.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nebesio TD, Hoover WC, Caldwell RL, Nitu ME, Eugster EA. Development of pulmonary hypertension in an infant treated with diazoxide. J Pediatr Endocrinol Metab 2007; 20: 939-44.","DOI":"10.1515\/JPEM.2007.20.8.939"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Demirel F, Unal S, \u00c7etin II, Esen I, Arasli A. Pulmonary hypertension and reopening of the ductus arteriosus in an infant treated with diazoxide. J Pediatr Endocrinol Metab 2011; 24: 603-5.","DOI":"10.1515\/jpem.2011.238"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Timlin MR, Black AB, Delaney HM, Matos RI, Percival CS. Development of pulmonary hypertension during treatment with diazoxide: A case series and literature review. Pediatr Cardiol 2017; 38: 1247-50.","DOI":"10.1007\/s00246-017-1652-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kylat RI. Pulmonary hypertension occurring with diazoxide use in a preterm infant with hypoglycemia. Drug Healthc Patient Saf 2019; 11: 7-10.","DOI":"10.2147\/DHPS.S198255"},{"key":"8","unstructured":"8. Food and Drug Administration. FDA Drug Safety Communication. FDA warns about aserious lung condition in infants and newborns treated with Proglycem (diazoxide). Available at: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-about-serious-lung-condition-infants-and-newborns-treated. Accessed December 26, 2019."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Pruitt AW, Dayton PG, Patterson JH. Disposition of diazoxide in children. Clin Pharmacol Ther 1973; 14: 73-82.","DOI":"10.1002\/cpt197314173"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hu HL, Zhang ZX, Chen CS, Cai C, Zhao JP, Wang X. Effects of mitochondrial potassium channel and membrane potential on hypoxic human pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol 2010; 42: 661-6.","DOI":"10.1165\/rcmb.2009-0017OC"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Taraseviciene-Stewart L, Kasahara Y, Alger L, <i>et al<\/i>. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J 2001; 15: 27-38.","DOI":"10.1096\/fj.00-0343com"},{"key":"12","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/01.CIR.98.14.1400","volume":"98","year":"1998","unstructured":"12. Yuan JX, Aldinger AM, Juhaszova M, <i>et al<\/i>. Dysfunctional voltage-gated K+ channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension. Circulation 1998; 98: 1400-6.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995; 333: 214-21.","DOI":"10.1056\/NEJM199507273330403"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Fukutomi M, Shimodera M, Maeda Y, Iwakura M, Hara M. Safety and effectiveness, including intelligence prognosis, of diazoxide in pediatric patients with hyperinsulinemic hypoglycemia: Special survey in Japan (long-term, all-case survey). Clin Pediatr Endocrinol 2018; 27: 131-43.","DOI":"10.1297\/cpe.27.131"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/5\/61_20-024\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T03:56:26Z","timestamp":1601697386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/5\/61_20-024\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-024","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]}}}